Controversies in lung cancer screening

Copyright © 2013 American College of Radiology. Published by Elsevier Inc. All rights reserved..

There remains an extensive debate over lung cancer screening, with lobbying for and against screening for very compelling reasons. The National Lung Screening Trial, International Early Lung Cancer Program, and other major screening studies favor screening with low-dose CT scans and have shown a reduction in lung cancer--specific mortality. The increasing incidence of lung cancer and the dismal survival rate for advanced disease despite improved multimodality therapy have sparked an interest in the implementation of national lung cancer screening. Concerns over imaging workflow, radiation dose, management of small nodules, overdiagnosis bias, lead-time and length-time bias, emerging new technologies, and cost-effectiveness continue to be debated. The authors address each of these issues as they relate to radiologic practice.

Errataetall:

ReprintIn: J Am Coll Radiol. 2016 Feb;13(2 Suppl):R2-7. - PMID 26846531

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Journal of the American College of Radiology : JACR - 10(2013), 12 vom: 01. Dez., Seite 931-6

Sprache:

Englisch

Beteiligte Personen:

Gill, Ritu R [VerfasserIn]
Jaklitsch, Michael T [VerfasserIn]
Jacobson, Francine L [VerfasserIn]

Links:

Volltext

Themen:

CT scan
Journal Article
Low-dose CT
Lung cancer
Lung cancer screening
Overdiagnosis bias
Tumor volume doubling time

Anmerkungen:

Date Completed 30.07.2014

Date Revised 28.11.2016

published: Print

ReprintIn: J Am Coll Radiol. 2016 Feb;13(2 Suppl):R2-7. - PMID 26846531

Citation Status MEDLINE

doi:

10.1016/j.jacr.2013.09.013

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM233259430